Ironwood Pharmaceuticals (IRWD) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to 0.67.
- Ironwood Pharmaceuticals' Equity Ratio rose 1655.49% to 0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67, marking a year-over-year increase of 1655.49%. This contributed to the annual value of 0.86 for FY2024, which is 1681.49% down from last year.
- Per Ironwood Pharmaceuticals' latest filing, its Equity Ratio stood at 0.67 for Q3 2025, which was up 1655.49% from 0.9 recorded in Q2 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' Equity Ratio peaked at 0.61 during Q1 2023, and registered a low of 1.02 during Q1 2025.
- Moreover, its 5-year median value for Equity Ratio was 0.57 (2023), whereas its average is 0.17.
- As far as peak fluctuations go, Ironwood Pharmaceuticals' Equity Ratio surged by 438040.97% in 2021, and later crashed by 22400.99% in 2023.
- Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Equity Ratio stood at 0.54 in 2021, then grew by 10.25% to 0.59 in 2022, then plummeted by 224.01% to 0.74 in 2023, then dropped by 16.81% to 0.86 in 2024, then rose by 22.33% to 0.67 in 2025.
- Its last three reported values are 0.67 in Q3 2025, 0.9 for Q2 2025, and 1.02 during Q1 2025.